All charges against ex-Vungle CEO Zain Jaffer have been dismissed at the request of San Mateo DA, who said prescribed drugs from multiple doctors were at fault
Context & Ripple Effects
In October 2017, Vungle placed CEO Zain Jaffer on indefinite leave within a day of his arrest on attempted murder and lewd act charges, leaving the video ad startup — which had raised $25.5M — without its founder at the helm. Nine months later, the San Mateo DA has asked for all charges to be dismissed, attributing the incident to prescribed drugs coming from multiple doctors rather than criminal intent.
The dismissal closes the criminal chapter but not the governance one: Vungle operated through the entire episode with its CEO sidelined, and the DA's stated cause — overlapping prescriptions from several physicians — lands in the same territory as later prosecutions of prescribing pipelines, including the Done Global Adderall case.
First-order effects
- Jaffer is legally cleared of all charges, but Vungle has already run nine months without him as an active CEO, so the dismissal forces a decision on whether the founder returns or the leave becomes permanent separation.
Second-order effects
- The DA's attribution of the incident to multiple doctors prescribing overlapping drugs shifts scrutiny from the executive to the prescribers, putting the physicians involved at risk of licensing review and feeding the broader enforcement climate around prescription practices seen in cases like Done Global.
Third-order effects
- If the pattern holds, startup boards will treat founder criminal charges as a governance trigger requiring immediate structural separation — leave, interim leadership — regardless of eventual acquittal, because reputational damage accrues during the process, not just at conviction.
The trend: Executive criminal cases are increasingly turning on medical and pharmacological causation, while regulators tighten their focus on how patients end up with prescriptions from multiple doctors.